Initiator Pharma A/S (STO:INIT)
Sweden · Delayed Price · Currency is SEK 3.250
+0.030 (0.93%)
Apr 10, 2026, 5:01 PM CET
Initiator Pharma Market Cap
Initiator Pharma has a market cap or net worth of 220.42 million as of April 10, 2026. Its market cap has decreased by -40.53% in one year.
Market Cap
220.42M
Enterprise Value
185.50M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.25
Market Cap Chart
Since March 16, 2017, Initiator Pharma's market cap has increased from 50.37M to 220.42M, an increase of 337.63%. That is a compound annual growth rate of 17.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 220.42M | 8.78% |
| Dec 30, 2025 | 202.62M | -47.31% |
| Dec 30, 2024 | 384.53M | -20.69% |
| Dec 29, 2023 | 484.84M | 52.80% |
| Dec 30, 2022 | 317.31M | -10.94% |
| Dec 30, 2021 | 356.31M | 167.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sprint Bioscience AB | 275.40M |
| Intervacc AB | 274.70M |
| Elicera Therapeutics AB | 263.55M |
| Mendus AB | 261.96M |
| Diamyd Medical AB | 237.13M |
| Xintela AB | 221.35M |
| AlzeCure Pharma AB | 182.71M |
| Isofol Medical AB | 181.88M |